Clinical Trial News and Research

RSS

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

SHEFFIELD Teaching Hospitals NHS Foundation Trust has become the first NHS hospital in the UK to start offering its patients a new non-invasive treatment for wet age-related macular degeneration (wet AMD).

20 Aug 2014

First Edition: August 20, 2014

Today's headlines include a report from California that Anthem Blue Cross is being sued again regarding its narrow-network health plans as well as a prediction from Maryland officials regarding the state's online insurance marketplace.

20 Aug 2014

Natural killer cells can be used to combat acute lymphoblastic leukemia

Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that can be used to destroy the cancer cells.

19 Aug 2014

Doctors test device designed to 'turn off' cluster headaches

For those suffering excruciating pain from cluster headaches, relief may soon be available from an investigational device being studied in a national multicenter clinical trial. Recently, doctors at The Ohio State University Wexner Medical Center performed the first surgery in the United States to insert a neurostimulator to provide relief from cluster headaches, which are more painful than migraines.

19 Aug 2014

FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata

Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.

18 Aug 2014

Microbes influence human eating behavior, dietary choices

It sounds like science fiction, but it seems that bacteria within us — which outnumber our own cells about 100-fold — may very well be affecting both our cravings and moods to get us to eat what they want, and often are driving us toward obesity.

17 Aug 2014

Loyola dermatopathologist recognized by ASCP for achievements in the medical laboratory field

Dermatopathologist, Jodi J. Speiser MD, Assistant Professor of Pathology, Loyola University Stritch School of Medicine, has been named one of the American Society for Clinical Pathology's "40 Under 40" for her achievements in the medical laboratory field.

16 Aug 2014

Anti-EphA3 antibody has anti-tumour effects against solid cancers

An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects.

16 Aug 2014

Enzyme therapy may prevent skeletal abnormalities associated with neurofibromatosis type-1

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.

15 Aug 2014

Modified C. novyi-NT bacterium produces precisely targeted anti-tumor response

A modified version of the Clostridium novyi (C. novyi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer Center researchers.

14 Aug 2014

Clinical trial tests COXEN model in bladder cancer to find promising treatment

Imagine being able to match a cancer's genes to the best treatment. That's the promise of COXEN (CO eXpression ExtrapolatioN) - a computer program that looks at a panel of cancer genes in a patient's tumor to predict whether it will respond to chemotherapy.

14 Aug 2014

AEG-1 protein blocks effects of retinoic acid in leukemia and liver cancer

Retinoic acid is a form of vitamin A that is used to treat and help prevent the recurrence of a variety of cancers, but for some patients the drug is not effective.

14 Aug 2014

Healthy men participating in Prostate Cancer Prevention Trial are most likely to undergo biopsy

Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all steps of the clinical trial are most likely to undergo a biopsy, according to a study published in Cancer Epidemiology, Biomarkers and Prevention - a journal of the American Association for Cancer Research.

14 Aug 2014

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.

13 Aug 2014

Neovasc revenues increase 58% to $4,404,515 in Q2 2014

Neovasc Inc. ("Neovasc" or the "Company") today announced financial results for the three months ended March 31, 2014. All results are reported in Canadian dollars unless otherwise stated.

13 Aug 2014

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).

13 Aug 2014

Clinical Trial News and Research

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

First Edition: August 20, 2014

Natural killer cells can be used to combat acute lymphoblastic leukemia

Doctors test device designed to 'turn off' cluster headaches

FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata

Microbes influence human eating behavior, dietary choices

Loyola dermatopathologist recognized by ASCP for achievements in the medical laboratory field

Anti-EphA3 antibody has anti-tumour effects against solid cancers

Enzyme therapy may prevent skeletal abnormalities associated with neurofibromatosis type-1

Modified C. novyi-NT bacterium produces precisely targeted anti-tumor response

Clinical trial tests COXEN model in bladder cancer to find promising treatment

AEG-1 protein blocks effects of retinoic acid in leukemia and liver cancer

Healthy men participating in Prostate Cancer Prevention Trial are most likely to undergo biopsy

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

Neovasc revenues increase 58% to $4,404,515 in Q2 2014

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

VolitionRx installs automated liquid handling system to increase rate of blood sample analysis

Experts open new clinic to evaluate heart disease patients for participation in stem cell studies

Study shows castor bean oil reduces epileptic seizures related to Glut1 deficiency

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery